Intervertebral Spacers Market Size is set to gain significant traction from 2022 to 2028, on account of the increasing adoption of minimally-invasive surgical procedures and rapid technological advancements. Intervertebral spacers or interspinous spacers refer to small devices that are implanted in between vertebral spinous processes, to offer stabilization after decompressive surgery or as a replacement for decompressive surgery. These devices help reduce pain in patients suffering from conditions like neurogenic claudication or lumbar spinal stenosis.
One of the major factors powering intervertebral spacers market trends over 2022-2028 is the rapid expansion of the geriatric population worldwide and the subsequent rise in demand for spinal surgeries. According to estimates from the WHO, 1 in 6 people globally are expected to be over 60 years of age by 2030. One of the most common wear-and-tear impacts of aging is the narrowing of the spinal canal, which encompasses the spinal cord and spinal nerves, known as spinal stenosis. Degenerative effects like spinal stenosis are observed in almost 95% of people by 50 years of age, leading to a surge in demand for intervertebral spacers as an important treatment response to the condition.
Hospitals are set to emerge as a prominent application segment for the intervertebral spacers industry by 2028. This growth is credited mainly to the rising rate of spinal disorder-related hospitalizations, and the ability of hospitals to offer advanced surgical technologies for minimally invasive procedures to treat spinal disorders. In April 2021, Stamford Health’s HSS Orthopedics became the first healthcare provider in the region to launch a next-generation computerized AR (augmented reality) navigation technology for spinal surgeries. By equipping spine surgeons with “x-ray vision”, the technology is designed to improve visualization through tissues surrounding the patient’s spine, in order to facilitate faster and more accurate surgeries.
From a regional standpoint, Europe is set to emerge as a lucrative revenue prospect for the intervertebral spacers industry by 2028, owing to the growing geriatric population with spinal disorders and the increasing approval for advanced spinal products. To illustrate, in June 2021, Integrity Implants Inc., a leading provider of Adaptive Geometry technology for ground-breaking spinal surgery solutions, gained CE mark approval for the FlareHawk Expandable Lumbar Interbody Fusion Device, its flagship product.
Some of the prominent players operating in the intervertebral spacers market include Globus Medical Inc., Universal Orthosystems, Orthoneu Surgicals, DePuy Synthes, Intromed (Flexan LLC), Aesculap, and Medinorm. Mergers, acquisitions, and partnerships are among the key strategies being employed by these companies to boost their presence in the global market. To illustrate, in September 2021, Evonik joined hands with Samaplast to combine their expertise for the development of a PEEK osteoconductive biomaterial for injective molding. Through the collaboration, the companies are documenting and demonstrating the advanced processing attributes of the VESTAKEEP Fusion osteoconductive high-performance polymer using the first spinal implant prototypes.
The COVID-19 pandemic has asserted a major impact on healthcare systems across the globe. At the peak of the crisis, various strategies were put into effect to mitigate the risk of virus transmission between healthcare workers and patients, including minimization of elective surgeries. However, delay in treatment for certain spinal conditions can cause significant neurological deterioration with rapid progression of limb numbness and pain. This, in turn, has led to numerous efforts to improve patient management during the pandemic, to improve spinal disorder treatment, which could boost intervertebral spacers market demand. In January 2020, for example, NASS (North American Spine Society) created a guidance document to facilitate triaging of spine cases, categorizing them either as emergent, urgent or elective, with early surgical intervention recommended for emergent cases, in order to improve clinical outcomes.
Market, by Material
Market, by Application
Market, by End-use
The above information is provided for the following regions and countries: